Blog

Blog2023-08-08T17:17:12-04:00

Using the EPDS to Screen for Anxiety Disorders: Conceptual and Methodological Considerations

The Edinburgh Postnatal Depression Scale (EPDS) was designed to screen women for postnatal depression.  Cox and Holden (2003) state that the EPDS was not designed to measure anxiety.  However, recent emphasis on the importance of recognizing symptoms of perinatal anxiety disorders, coupled with findings in research, have led to the suggestion that the EPDS may be used as a multidimensional tool to screen for anxiety disorders in addition to depression during the perinatal period (Matthey et al, 2012).

March 11th, 2013|

Exposure to Valproic Acid and Increased Risk of Autism Spectrum Disorders

There have long been concerns regarding the use of the anticonvulsant valproate (Depakote, VPA) during pregnancy. First trimester use of valproate has been associated with a 3-5% risk of neural tube defects, as well as an increased risk of other malformations affecting the heart and other organ systems.  Multiple reports have also indicated that in utero exposure to valproate may also negatively affect cognitive development.

March 4th, 2013|

Antidepressants and Pregnancy: A Meta-Analysis Puts the Risks into a Larger Context

While some studies have shown an association between in utero exposure to antidepressants and various pregnancy outcomes, including preterm delivery, low birth weight, and lower Apgar scores, these outcomes have also been linked to untreated maternal depression. Thus, it has been difficult to determine if there is a causal relationship between antidepressant exposure and negative pregnancy outcomes or whether maternal depression is itself responsible for these negative outcomes.

March 1st, 2013|

Screening for Peripartum Anxiety Disorders: What Are the Best Screening Tools?

A significant number of women experience anxiety symptoms during pregnancy, with about 8.5% of women meeting criteria for generalized anxiety disorder.  Other anxiety disorders are less common.   The estimated prevalence of panic disorder during pregnancy is 1-2%.   The estimated prevalence of obsessive-compulsive disorder is 0.2-1.2%.  While we use certain tools, including the Edinburgh Postnatal Depression Scale (EPDS) to screen for depression during pregnancy, what are the best tools for indentifying women with clinically significant anxiety symptoms?

February 12th, 2013|

What’s Worse for Pregnancy: Bipolar Disorder or the Medications Used to Treat It?

In studies of pregnant women with unipolar depression, it has been shown that untreated psychiatric illness in the mother may have a negative impact on pregnancy outcomes, influencing the length of gestation and birthweight.  There is far less data on pregnancy outcomes in women with bipolar disorder.  A recent Swedish study analyzes pregnancy outcomes in treated and untreated women with bipolar disorder and attempts to distinguish between the effects of medication versus the effects of untreated psychiatric illness in the mother.

February 5th, 2013|
Go to Top